Filing Details
- Accession Number:
- 0001140361-12-001905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-11 10:45:03
- Reporting Period:
- 2012-01-10
- Filing Date:
- 2012-01-11
- Accepted Time:
- 2012-01-11 10:45:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1081916 | J Thomas Tisch | 667 Madison Avenue New York NY 10065 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-10 | 1,200,000 | $25.18 | 341,935 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 316,021 | Indirect | Through trusts |
Footnotes
- This statement is being filed solely for informational purposes because of family relationships. The filing of this statement is not an admission that the reporting person and any other person or persons constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934 or Rule 13d-5 thereunder or for any other purpose, and the reporting person disclaims beneficial ownership of any shares other than those reported herein.
Billionaire Hedge Funds
